• +1 700 888 1234

  • Effingerstrasse 40 3008 Bern Switzerland

EMOTIONAL AND SOCIAL IMPACT OF LUNG CANCER ON PATIENTS AND CAREGIVERS

Since its establishment, LuCE has continually developed a range of reports tackling relevant challenges for the lung cancer community, such […]

A WARM WELCOME TO LUCE’S NEW BOARD

LuCE’s newly elected board members as of 09/05/2020: Anne-Marie Baird – President Ewelina Szmytke – Vice-President Regine Deniel Ihlen – […]

COVID 19: FAQS FOR PEOPLE WITH LUNG CANCER

The responses are for informational use only―they don’t substitute the medical advice. If you have specific questions about your own […]

COVID-19 (CORONA VIRUS) AND LUNG CANCER

What is COVID-19? COVID-19 is an illness caused by a novel (new) coronavirus that was identified in December 2019. On […]

LUCE WEBINAR ON THE ROLE OF THE EUROPEAN MEDICINES AGENCY

In depth webinar held on 26th of February 2020 with Kate Morgan, from Myeloma Patients Europe about the role of the […]

LUNG CANCER EUROPE: 2020 POSITION PAPER. DISPARITIES AND CHALLENGES IN ACCESS TO LUNG CANCER DIAGNOSIS AND TREATMENT ACROSS EUROPE

Lung cancer is responsible for nearly 1 in 5 cancer related deaths in Europe, yet it remains a cancer that […]


Privacy policy
Terms & Conditions

© 2025 Lung Cancer Europe – All Rights Reserved